Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration

NCT03735225 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoglycemia

Interventions

DRUG: Dasiglucagon
DRUG: Placebo

Sponsor

Zealand Pharma